{"text": ["Alnylam", "to", "Pursue", "Full", "Approval", "&", "Rolling", "NDA", "for", "Givosiran"], "created_at": "2018-10-16 22:08:19"}
{"text": ["Alnylam", "to", "Pursue", "Full", "Approval", "&", "Rolling", "NDA", "for", "Givosiran"], "created_at": "2018-10-16 22:08:19"}
{"text": ["Tesla", "Jumps", "After", "Judge", "Makes", "SEC", "Settlement", "Official:", "LIVE", "MARKETS", "BLOG"], "created_at": "2018-10-16 17:02:00"}
{"text": ["Benchmark", "Out", "Bullish", "On", "'Well-Positioned'", "Tilray", "Ahead", "of", "Canada's", "Cannabis", "Legalization"], "created_at": "2018-10-16 14:26:14"}
{"text": ["Tilray", "Jumps", "After", "$200", "Price", "Target", "and", "'Buy'", "Rating:", "LIVE", "MARKETS", "BLOG"], "created_at": "2018-10-16 14:07:00"}
{"text": ["Tilray", "Jumps", "After", "$200", "Price", "Target", "and", "Bullish", "Rating", "at", "Benchmark"], "created_at": "2018-10-16 13:49:00"}
{"text": ["Roche", "Announces", "Positive", "Data", "on", "Breast", "Cancer", "Drug", "Kadcyla"], "created_at": "2018-10-16 13:39:01"}
{"text": ["Amgen,", "Novartis", "kick", "off", "fight", "for", "AbbVie", "blockbuster", "drug", "in", "EU"], "created_at": "2018-10-16 12:28:50"}
{"text": ["Tilray&apos;s", "stock", "surges", "after", "Benchmark", "starts", "coverage", "with", "bullish", "rating,", "$200", "target"], "created_at": "2018-10-16 12:00:00"}
{"text": ["Novartis", "To", "Present", "Five-year", "Data", "From", "Phase", "III", "Studies", "For", "Cosentyx"], "created_at": "2018-10-16 01:42:00"}
{"text": ["Novartis", "To", "Present", "Five-year", "Data", "From", "Phase", "III", "Studies", "For", "Cosentyx"], "created_at": "2018-10-16 01:42:00"}
